4//SEC Filing
WENTWORTH KORY JAMES 4
Accession 0001689375-25-000019
CIK 0001689375other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:34 PM ET
Size
6.8 KB
Accession
0001689375-25-000019
Insider Transaction Report
Form 4
WENTWORTH KORY JAMES
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-04-03$2.10/sh+11,134$23,381→ 120,670 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-04-03−11,134→ 20,023 totalExercise: $2.10Exp: 2030-11-10→ Common Stock (11,134 underlying)
Footnotes (1)
- [F1]The shares subject to this option fully vested on November 16, 2024.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001725663
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:34 PM ET
- Size
- 6.8 KB